Seattle, June 24, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global interventional neurology market is estimated to be valued at US$ 2,450.6 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Interventional Neurology Market:
Major players operating in market are focusing on adopting strategies such as receiving product approvals, which is expected to drive the market growth over the forecast period.
For instance, in April 2022, Boston Scientific Corporation, providing innovative medical solutions, received the U.S. Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The EMBOLD Fibered Coil was designed for use in a variety of embolization procedures, a minimally invasive treatment intended to block one or more blood vessels to obstruct or reduce blood flow.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/56
Key Market Takeaways:
Global interventional neurology market is expected to exhibit a CAGR of 5.3% during the forecast period due to the increasing adoption of inorganic strategies such as collaborations and agreements by the key players in market. For instance, in February 2022, Cardiovascular Systems (CSI), a medical device company, and Innova Vascular, engaged in…
